Back
ESC Premium Access

Titration of telmisartan, but not addition of amlodipine, reduces urine albumin in hypertensive patients with diabetes treated with telmisartan plus diuretic

Session: Cardiomyopathy with preserved ejection fraction: Amyloidosis and hypertension
Topic: Drug therapy
Speaker: Professor Y. Dohi (Nagoya, JP)
Event: ESC Congress 2016

Congress Presentation

About the speaker

Professor Yasuaki Dohi

Nagoya Gakukin University, Nagoya (Japan)
0 follower

5 more presentations in this session

Prevalence of cardiomyopathy in patients with familial amyloid neuropathy: a report from the NEURO-TTR Trial

Speaker: Assistant Professor S. Heitner (South San Francisco, US)

Access
Abstract
Slides
Thumbnail

Bortezomib: an effective therapy even in cardiac AL patients previously deemed unsalvageable

Speaker: Doctor A. Singh (Boston, US)

Access
Abstract
Slides
Thumbnail

Higher prevalence of hypertension in the migrant population in Italy: data derived from the 2012 and 2013 world kidney day

Speaker: Associate Professor S. Perlini (Pavia, IT)

Access
Abstract
Slides
Thumbnail

Impact of patients' wealth categories on antihypertensive drugs intake in 12 sub-saharan countries: EIGHT Study

Speaker: Doctor M. Antignac (Paris, FR)

Access
Abstract
Slides
Thumbnail

Impact of impaired cardiac function on the progression of chronic kidney disease---role of pharmacomodulation of valsartan

Speaker: Associate Professor S. Chua (Kaohsiung, TW)

Access
Abstract
Slides
Thumbnail

Access the full session

Cardiomyopathy with preserved ejection fraction: Amyloidosis and hypertension

Speakers: Professor Y. Dohi, Assistant Professor S. Heitner, Doctor A. Singh, Associate Professor S. Perlini, Doctor M. Antignac...
Access
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb